Possible neuromarker for 'juvenile-onset' Batten disease

Researchers find that an easy-to-measure brain process may be a target or biomarker in measuring treatment outcomes in clinical trials in Batten disease.


http://dlvr.it/T171gD

Yorumlar

Bu blogdaki popüler yayınlar

Lengthened consonants mark the beginning of words

Study of former NFL players finds 1 in 3 believe they have CTE